We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Philips Acquires Respiratory Technologies to Expand Product Portfolio

By HospiMedica International staff writers
Posted on 29 May 2017
Royal Philips has signed an agreement to acquire Respiratory Technologies, Inc., which provides airway clearance solution for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. More...
The addition of RespirTech’s vest therapy solution and capabilities to Philips’ respiratory care portfolio will further strengthen Philips’ solutions to manage care in the hospital and at home.

Philips’ solutions for managing COPD, asthma and other respiratory conditions at home or in the hospital range from air purification to therapies - including airway clearance devices, oxygen, ventilation and respiratory drug delivery systems - and monitoring. RespirTech’s offerings will allow Philips to accelerate its growth in respiratory care, especially for COPD patients with bronchiectasis, an often under-diagnosed and undertreated co-morbidity.

RespirTech’s inCourage System technology, a proprietary design that pulsates a vest worn by the patient at home, complements Philips’ solutions. Additionally, RespirTech has established a proprietary COPD/bronchiectasis registry involving more than 5,000 patients who are using its vest therapy. The collected data includes patient-reported changes in lung function, hospitalizations, antibiotic use and quality of life after initiating vest therapy. RespirTech’s clinical support program for managing respiratory patients in the home will support Philips’ aim to deliver cost-effective, clinically focused service programs, such as its sleep-focused Patient Adherence Management Service (PAMS).

“With this transaction, we will broaden our portfolio with a proven therapy to enable patients with chronic respiratory disorders manage their condition and receive the care they need in the home,” said John Frank, Philips’ Business Leader, Sleep & Respiratory Care. “RespirTech’s vest therapy can be applied to a range of respiratory conditions and various neuromuscular diseases, where patients’ compromised abilities to cough often leads to serious respiratory complications and associated higher care costs. By helping these patients help themselves, we aim to enhance the patient’s quality of life and reduce the overall cost of care.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.